Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC3 | Q9UHC3 | 3/20 | 0.67 |
| ▸ | CCR1 | P32246 | 3/20 | 0.48 |
| ▸ | CCR5 | P51681 | 3/20 | 0.48 |
| ▸ | CCR8 | P51685 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9132100 | 0.97 | ASIC3 (0.64) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL9151109 | 0.97 | ASIC3 (0.64) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL9132675 | 0.97 | ASIC3 (0.64) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL4361201 | 0.90 | ASIC3 (0.57) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| Dalfampridine SCHEMBL9979017 | 0.90 | MAPT (0.62) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL30173828 | 0.90 | ASIC3 (0.57) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL30337333 | 0.87 | ASIC3 (0.79) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL21386824 | 0.86 | CCR1 (0.74) | ASIC3CCR1CCR5CCR8CHRM1 | |
| SCHEMBL30253423 | 0.86 | ASIC3 (0.64) | ASIC3CCR1CCR5CCR8SMN1; SMN2 | |
| SCHEMBL247730 | 0.86 | ASIC3 (0.64) | ASIC3CCR1CCR5CCR8SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025217208-A1 | CHEMICAL MECHANICAL PLANARIZATION POLISHING FOR INTERCONNECTS DIFFUSION BARRIER MATERIALS | VERSUM MATERIALS US, LLC (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| CN-119332301-A | High-durability composite proton exchange membrane and preparation method thereof | 上海恩捷新材料科技有限公司 | 2025-01-21 | — | — | CN | claimed |
| US-20230398077-A1 | SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-12-14 | — | — | US | claimed |
| CN-112898349-B | Manganese metal complex with 4,4 '-diamino-2, 2' -bipyridine as ligand, and synthetic method and photocatalytic application thereof | 云南师范大学 | 2023-10-03 | — | — | CN | claimed |
| EP-4237091-A1 | A SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-09-06 | — | — | EP | claimed |
| CN-116606640-A | Iridium metal organic compound covalent functionalized graphene oxide ternary nano hybrid material and preparation method thereof | 江苏大学 | 2023-08-18 | — | — | CN | claimed |
| CN-113968970-B | Polyimide film with low thermal expansion coefficient and preparation method and application thereof | 浙江中科玖源新材料有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-115677972-A | Tough type light-operated self-repairing lignin-based polyurethane and preparation method and application thereof | 华南理工大学 | 2023-02-03 | — | — | CN | claimed |
| CN-111068787-B | Hydrogen peroxide hydrogenation catalyst, preparation method and application thereof | 东莞东阳光科研发有限公司 | 2022-12-27 | — | — | CN | claimed |
| EP-1349962-A4 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INST OF TECHN (US) | 2007-08-08 | — | — | EP | claimed |
| WO-2007084380-A2 | COMPOUNDS AND METHODS FOR NUCLEIC ACID MISMATCH DETECTION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2007-07-26 | — | — | WO | claimed |
| US-6808884-B2 | INTERCALATION COMPOUND FOR USE IN THE DIAGNOSIS AND DETECTION OF GENETIC DISORDERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-10-26 | — | — | US | claimed |
| WO-2002057492-A9 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INST OF TECHN (US) | 2003-12-18 | — | — | WO | claimed |
| EP-1349962-A1 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-08 | — | — | EP | claimed |
| US-20020155470-A1 | Methods and compositions for detecting polynucleotide duplex damage and errors | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-10-24 | — | — | US | claimed |
| WO-2002057492-A1 | METHODS AND COMPOSITIONS FOR DETECTING POLYNUCLEOTIDE DUPLEX DAMAGE | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-07-25 | — | — | WO | claimed |
| EP-0237185-B1 | USE OF A PHOTOSENSITIVE CATHODE FOR DEPOSITION OF METAL STRUCTURES WITHIN ORGANIC POLYMERIC FILMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-01-31 | — | — | EP | claimed |
| EP-0237185-A1 | Use of a photosensitive cathode for deposition of metal structures within organic polymeric films | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-09-16 | — | — | EP | claimed |
| US-4657833-A | PHOTOSENSITIVE MATERIAL AT INTERFACE OF TRANSPARENT ELECTRODE AND POLYMER FILM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020155470-A1 | Methods and compositions for detecting polynucleotide duplex damage and errors | POLRMT, POLN, POLM | ASIC3 2464/4885CCR1 3874/4885CCR5 4003/4885 |
| US-20230398077-A1 | SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY | CD47, SGMS1, ABCC1 | ASIC3 1357/4885CCR1 393/4885CCR5 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.